Evidence map›Paper›PMID 40675796›Full record

ArticleJournal of medical ethics2026

When to create embryos or organoids for research.

Sebastian Porsdam Mann, Julian Savulescu, Brian D Earp

Abstract read
In one paragraph

Article in Journal of medical ethics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Organoids for disease modeling and treatment: state-of-the-art.Experimental hematology & oncology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sebastian Porsdam MannCenter for Advanced Studies in Bioscience Innovation Law (CeBIL), University of Copenhagen, Copenhagen, DK.ORCID http://orcid.org/0000-0002-1867-2097
Julian SavulescuCentre for Biomedical Ethics, National University of Singapore Yong Loo Lin School of Medicine, Singapore julian.savulescu@uehiro.ox.ac.uk.ORCID http://orcid.org/0000-0003-1691-6403
Brian D EarpCentre for Biomedical Ethics, National University of Singapore Yong Loo Lin School of Medicine, Singapore.ORCID http://orcid.org/0000-0001-9691-2888

Funding

Wellcome Trust
6 · The paper itself

Abstract

The development of brain organoids and use of human embryonic neural structures for research each raise distinct ethical considerations that require careful analysis. We propose that rather than attempting to resolve longstanding debates about embryonic moral status, a more productive approach is to examine how different positions on this fundamental question lead to distinct conclusions about appropriate research strategies. For those who ground moral status in species membership or developmental potential, even early-stage embryo research may be ethically impermissible, suggesting focus on carefully bounded organoid development. Conversely, for those who ground moral status in current capacities, embryonic neural tissue studied before the emergence of consciousness may offer significant advantages over organoids while raising fewer novel ethical concerns. Our analysis reveals inadequacies in current policies, particularly the 14-day rule, which appears difficult to justify under either ethical framework. We demonstrate how careful attention to the relationship between ethical premises and research implications can advance both scientific progress and ethical oversight, while suggesting specific policy reforms including capacity-based research guidelines and sophisticated monitoring protocols.

Indexed as

BrainEmbryo ResearchOrganoidsAnimalsEthics, ResearchHumansMoral StatusEmbryo ResearchEmbryos and FetusesEthics, ResearchMoral Status

Identifiers

PMID40675796
PMCPMC13479282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.